Global Medical REIT (GMRE) Misses Q2 EPS by 2c ; Provides Outlook

Global Medical REIT (NYSE: GMRE) reported Q2 EPS of ($0.01), $0.02 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $37.9 million versus the consensus estimate of $35.39 million.

2025 Guidance

The Company is reaffirming its full year 2025 AFFO per share and unit guidance of $0.89 to $0.93.

For earnings history and earnings-related data on Global Medical REIT (GMRE) click here.

You May Also Be Interested In

• Helen of Troy (HELE) Tops Q1 EPS by 22c, Beats on Revenue; Offers FY Guidance
• Ligand Pharma (LGND) PT Raised to $332 at Stifel as Xoma Asset Acquisition Announced
• IsoEnergy resumes uranium drilling in Athabasca Basin after wildfire pause